For analysis of multidrug resistance, a major barrier to effective cancer chemotherapy, we profiled mRNA expression of the 48 known human ABC transporters in 60 diverse cancer cell lines (the NCI-60) used by the National Cancer Institute to screen for anticancer activity. The use of real-time RT-PCR avoided artifacts commonly encountered with microarray technologies. By correlating the results with the growth inhibitory profiles of 1,429 candidate anticancer drugs tested against the cells, we identified which transporters are more likely than others to confer resistance to which agents. Unexpectedly, we also found and validated compounds whose activity is potentiated, rather than antagonized, by the MDR1 multidrug transporter. Such compounds may serve as leads for development.
Introduction
the functions of most members of the family. Given the high degree of similarity of ABC sequences, however, it seems plausible that additional members may also be drug exporters and The ABC (ATP binding cassette) family of membrane transport proteins includes the best-known mediators of resistance to may thus be associated with decreased sensitivity of cancer cells to chemotherapy. To explore that proposition, we wanted anticancer drugs. In particular, MDR (multidrug resistance) pumps ABCB1 (MDR1-P-gp), ABCC1-MRP1, and ABCG2-MXR to characterize ABC gene expression in a set of cancer cells whose responses to a large number of compounds are known (Gottesman et al., 2002; Cole et al., 1992; Borst et al., 2000; Deeley and Cole, 1997; Litman et al., 2001 ) actively extrude and whose molecular characteristics have been cataloged. The natural choice was a panel of 60 human cancer cell lines (the many types of drugs from cancer cells, thereby conferring resistance to those agents. More broadly, the ABC transporters ap-NCI-60) used by the Developmental Therapeutics Program (DTP) of the National Cancer Institute (NCI) to screen Ͼ100,000 pear to have evolved to defend the cell through recognition and energy-dependent removal of a large variety of natural toxic chemical compounds since 1990. Included among the 60 are leukemias, melanomas, and cancers of ovarian, breast, prosagents (Sarkadi et al., 1996) . Their functional significance is suggested by the observation that they form one of the largest tate, lung, renal, colon, and central nervous system origin. Patterns of drug activity across the cell lines and patterns of cell protein families, found in various cellular membranes of organisms from bacteria to mammals. Based on sequence homology, sensitivity across the set of tested drugs have been shown to contain detailed information on mechanisms of action and 48 different ABC transporters (grouped into seven subfamilies ranging from A to G) have been defined in the human genome.
resistance (Paull et al., 1989; Weinstein et al., 1992) . In addition to this pharmacological characterization, the NCI-60 cells have Their functions range from export of cholesterol (ABCA1) to regulation of chloride current (ABCC7-CFTR), and they play been more extensively profiled at the DNA, mRNA, protein, and functional levels than any other set of cells in existence. roles in the absorption, distribution, and excretion of pharmacological compounds.
Therefore, if we were to measure their expression of ABC transporters, it would be possible to link ABC transport function to Despite these generalizations, relatively little is known about
S I G N I F I C A N C E
Multidrug resistance of tumors is frequently associated with decreased cellular accumulation of anticancer drugs and elevated expression of ABC transporters such as MDR1. At present, relatively little is known about the substrate specificities of most ABC transporters. Here, we present a pharmacogenomic approach, in which we correlate expression profiles of all 48 human ABC transporters with patterns of drug activity in the NCI-60 cell lines. The findings are used to identify candidate substrates for several ABC transporters, as well as compounds whose toxicities are potentiated by ABCB1-MDR1. The gene expression database will serve as a high-quality "time capsule" that can be mined to generate new hypotheses and to illuminate additional features of ABC transporters and their functional relationships with other molecules. a variety of other molecular, physiological, and pharmacological of origin is moderate (see Supplemental Table S2) , as indicated by a statistic of 0.46 (with two-tailed 95% confidence interval ϭ features of the cells.
We wished to focus, in particular, on the relationship be-0.33-0.60). Interestingly, the two lumenal, estrogen receptorpositive breast lines (T47D and MCF7) cluster together. tween ABC expression levels and sensitivity to drugs or drug candidates, asking which of the transporters do (and which do This database provides valuable information on the expression patterns of both known and currently uncharacterized ABC not) confer resistance or sensitivity to various classes of agents. Previous transcript expression profiling of the NCI-60 using transporters. Some of them are expressed ubiquitously (e.g., ABCC1), whereas others are selectively expressed in particular cDNA arrays of Ͼ9000 elements (Scherf et al., 2000) and Affymetrix Hu6800 oligonucleotide chips (Staunton et al., 2001) cell types (e.g., ABCB5 in melanoma-derived cells; see inset in Figure 1 and Supplemental Table S3 ). Langmann et al. (2003) proved useful for identification of patterns and molecular biomarkers. However, those studies had three major limitations found high expression of ABCA2 in brain, ABCA3 in lung, and ABCB1 and ABCC4 in kidney. When analyzed by Monte Carlo with reference to the ABC transporters: (1) only 15 and 11 of the 48 transporters were represented in the cDNA and oligonupermutation t test, our data show that ABCA2 is ubiquitously expressed throughout the 60 lines (p Ͼ 0.61 for each of the cleotide arrays, respectively; the total combined coverage was only 17 of 48, and the mean correlation between the two sets nine tissues of origin), whereas ABCA3 is selectively expressed (p ϭ 0.039) in H522M, A549, and EKVX (all of them lung cancer for the 9 transporters represented in both was only ϩ0.43; (2) in part because of limited sensitivity, 64.2% and 58.5% of the lines). ABCB1 is indeed selectively expressed in the renal cancer cell lines (p ϭ 0.0059). However, ABCC4 is only moderately values were undetectable above background for the cDNA and oligonucleotide arrays, respectively; and (3) crosshybridization expressed in those cells (p Ͼ 0.145 for each of the nine tissues of origin). This apparent discrepancy with respect to the results among close family members could be expected, especially with the cDNA arrays, but also with the oligonucleotide arrays of Langman et al. may be due to heterogeneity of the human tissue samples used in that study, or may reflect distinctive insofar as they were not designed with central focus on the ABC transporters. Since reproducible, quantitative correlations characteristics of the cancer cells. The distribution of ABC transporters on the gene dendrogram appears to be independent of between expression and sensitivity were required for our study, we chose to measure transcript expression by the "gold stansequence-homology categories. ABCB2 and ABCB3, known to function as heterodimeric components of the ER transport dard" method, quantitative real-time RT-PCR, rather than the less sensitive, less specific microarray technology. Finding such system for peptide antigen presentation, are found in different clusters, suggesting that their reported coordinate expression correlations (and confirming them in follow-up studies) demonstrates the important role of ABC transporters in the drug resisis disrupted in the cancer cells. Conversely, ABCG5 and ABCG8, which also form a heterodimer, show the expected concordance tance of cancer cells. One striking result was the identification of at least one compound whose toxicity appears to be potentiin expression pattern across the 60 cells (see Figure 1 ). ated, rather than antagonized, by ABCB1 (MDR1).
Correlation of ABC transporter mRNA levels with drug resistance Results and discussion
In a previous study using cDNA microarrays, the 60 cell lines were found to cluster reasonably well by tissue of origin on the Forty-eight ABC proteins are coded by the human genome (see http://nutrigene.4t.com/humanabc.htm for a comprehenbasis of expression patterns determined for a broad range of genes, but they did not cluster as well on the basis of patterns sive database). Figure 1 shows a clustered image map ("heat map") (Weinstein et al., 1997) that offers a visual summary of of drug sensitivity (Scherf et al., 2000) . Furthermore, there was only a modest correspondence between the two clusterings. the patterns of ABC transporter expression across the 60 cell lines. The complete RT-PCR results on the 48 ABC transporters Hence, cell clusters in the present study that appear similar for both ABC transporter expression and drug activity patterns are (47 determined in this work and one previously reported [Prades et al., 2002] ) are presented in Supplemental Table S1 at http:// particularly interesting. Clusters such as that consisting of ACHN, UO-31, HCT15, and NCI-ADR-RES fall into that catewww.cancercell.org/cgi/content/full/6/2/129/DC1. A 49th ABC gene, ABCC13, is predicted to encode a nonfunctional protein gory. Not surprisingly, ABCB1 (i.e., MDR1) is highly expressed in those cells. (Yabuuchi et al., 2002) and therefore is not included in this study. Quantitative analysis showed that the pattern of expression is Since ABCB1 (MDR1-Pgp) extrudes molecules from the cell, the activity patterns of its substrates across the 60 cell lines most characteristic of tissue of origin for melanoma (9 of the 10 melanoma cells cluster together on the dendrogram). The are expected to be negatively correlated with its pattern of expression (Shoemaker, 2000; Lee et al., 1994) . Figure 2 indione melanoma line not found in the melanoma cluster (LOX-IMVI) is amelanotic and undifferentiated and has been shown cates that such is indeed the case for a set of 118 compounds with putatively known mechanisms of action (Weinstein et al., to lack transcripts characteristic of melanoma . MDA-MB435 and MDA-N were originally thought to be 1992). Reported substrates (e.g., geldanamycin, paclitaxel and its analogs, doxorubicin and vinblastine, and bisantrene [Lee et from breast cancer, but their appearance within the melanoma cluster is consistent with strong molecular profile evidence that al., 1994]), indicated by blue bars, show striking inverse correlations, whereas compounds not transported by MDR1 (e.g., hythey are melanoma-derived or at least melanoma-like (Scherf et al., 2000; Ellison et al., 2002; Ross et al., 2000) . MDA-N is droxyurea, camptothecins, methotrexate, and 5-fluorouracil) are invariably found to be noncorrelated or positively correlated (red an ERBB2 transfectant of MDA-MB435. CNS (5/6), renal (5/8), and ovarian (4/6) cells tend to form clusters, whereas the leukebars). Of the 118 compounds, only two inversely correlated drugs, an anthrapyrazole-derivative (NSC 355644, r ϭ Ϫ0.36) mia, colon, lung, breast, and prostate cancer cell lines do not cluster well by tissue of origin. Overall, the coherence by tissue and Baker's soluble antifol (NSC 139105, r ϭ Ϫ0.3), have not The hierarchical clustering on each axis was done using the average-linkage algorithm with 1Ϫr as the distance metric, where r is the Pearson's correlation coefficient, after subtracting row and column means. The inset highlights ABC transporters characteristically expressed in melanoma cells. For more details, see Supplemental Table S3 .
previously been established as MDR1 substrates (black bars). distribution of ABCB1 was heavily right-skewed (i.e., a small number of the cell lines expressed high levels of ABCB1 tranHowever, resistance to Baker's antifol is reversed by verapamil, a potent inhibitor of MDR1 transport, suggesting that it is indeed script), we were concerned that the correlations obtained might be based on the relationship of drug activity to MDR1 expression an MDR1 substrate (Gupta et al., 1988) .
To identify additional compounds that show significant inin only a subset of the cell types. Therefore, we also computed bootstrap distributions (based on 10,000 bootstrap samples) of verse correlation with the expression of ABCB1, we extended the analysis to a larger data set containing the activity patterns all correlations to obtain estimates of variability and confidence intervals with stringent significance levels. The 18 compounds of 1,429 compounds (Scherf et al., 2000) . Since the measured These results support the idea that correlation of ABCB1 expression with activity patterns in the 60 cell lines can be used to identify potential ABCB1 substrates among the Ͼ100,000 compounds tested at the NCI (Alvarez et al., 1995; Izquierdo et al., 1996; Bates et al., 1994; Wu et al., 1992) . The chemical properties of inversely correlated compounds may also help define the "common pharmacophore" of the structurally dissimilar MDR1 substrates (Scala et al., 1997; Pajeva and Wiese, 2002; Blower et al., 2002) . ABC proteins transport a wide variety of compounds through the lipid bilayer, and identification of transported molecules should help us understand the physiological mechanisms and specificities of the transporters. To identify which ABC transporters and substrates may play roles in drug resistance of cancer cells, we calculated Pearson's correlation coefficients for a total of 68,592 relationships (48 genes ϫ 1429 compounds; Supplemental Table S5 ) using bootstrap analysis with 10,000 iterations. The analysis yielded 131 highly inverse-correlated gene-drug pairs (Supplemental Table S6 ), sufficiently highly cor- ABC transporters. To verify this hypothesis, we performed independent followup experiments in defined systems for the most interesting correlative findings. As examples, we will describe here the results for two transporter drug pairs, one involving that survived this statistical screening share structural features ABCC2-MRP2, the other involving ABCC11. (large size, polyaromatic backbone, amphipathic character) with
The ABCC (MRP) subfamily is comprised of nine members the well-known MDR1 substrates (Rabow et al., 2002; Supple- that transport structurally diverse lipophilic anions and function mental Figure S1 at http://www.cancercell.org/cgi/content/ as drug efflux pumps . ABCC2-MRP2 full/6/2/129/DC1). NSC 328426 (phyllanthoside), NSC 259968 is a canalicular efflux pump with a role in the hepatobiliary (Bouvardin), and NSC 156625 (Coralyne) have been tested in excretion of bilirubin glucuronide as well as numerous pharmavarious laboratories and shown to interact with MDR1 (Lee et ceuticals. ABCC11, a recently identified member of the superal., 1994; Gupta et al., 1988) . The rest have not previously been family, has been shown to mediate the ATP-dependent transimplicated in MDR1-mediated resistance.
port of cyclic nucleotides and confer resistance to certain nucleotide analogs (Guo et al., 2003) . Of the 1429 compounds Evidence that correlations predict drug resistance analyzed in this study, 14 were shown by the stringent bootstrap due to ABC transporters criterion described above to be less active in cells that exTo test whether our approach using the NCI-60 does, in fact, pressed large amounts of ABCC2. One of these compounds identify new substrates, we used the MTT assay to test all topwas available from DTP for followup testing ( Figure 4A ). One scoring compounds that were available from DTP for follow-up compound was less active in the presence of large amounts of experiments. KB-3-1, a human carcinoma cell line, and KB-V1, ABCC11 ( Figure 4C , Supplemental Figure S1 , and Supplemental a multidrug resistant derivative of KB-3-1 that overexpresses Table S6 ). To verify whether these highly significant negative MDR1-P-gp (Shen et al., 1986) , were used for the tests. Figure  correlations indicate functional relationships, in which ABCC2 3 shows a typical result. When compared with the parental line, and ABCC11 protect the cells by exporting the related com-KB-V1 cells proved resistant to NSC 363997. PSC 833, an pounds, we compared control cells with ABCC2-transfected MDR1 antagonist, reversed the resistance, providing evidence or ABCC11-transfected derivatives in MTT assays. In sharp that the observed resistance was linked to P-gp function. Furcontrast to the control (sham-transfected) cells, the ABCC2-ther experiments showed that KB-V1 cells were 30-to 300-fold overexpressing MDCKII cells proved extremely resistant to NSC less sensitive than KB-3-1 cells to all 6 compounds available 641281, reinforcing the suggestion that NSC 641281 is an for study. This resistance of KB-V1 cells was invariably reversible ABCC2-MRP2 substrate ( Figure 4B ). Similarly, ABCC11-transby PSC 833. The intrinsic fluorescence of one of the comfected LLC-PK1 cells were 2-to 3-fold more resistant to NSC pounds, NSC 634791, allowed us to measure the effect of MDR1 671136 than were control, sham-transfected cells ( Figure 4D ), activity on its export from cells. Following incubation with NSC suggesting that ABCC11-mediated resistance can extend to 634791 for 10 min at 37ЊC, MDR1-positive cells contained less types of compounds other than nucleotide analogs. of the fluorescent compound than did the parental KB-3-1 cell
The real-time RT-PCR database and analytical approach line (Figure 3) . The decreased accumulation was completely presented here thus provide an unbiased method for disreversible by addition of PSC 833 (which had no effect on the covering the substrate specificities of known, as well as yet parental cells), further corroborating the hypothesis that NSC 634791 is an MDR1 substrate.
uncharacterized, members of the superfamily. Activity profiles of the 18 ABCB1 substrates were very strongly correlated with ABCD1-expression are therefore likely to be positively correlated with ABCB1 expression (Supplemental Table S5 ). expression of the transporter. In contrast, the other two molecules considered to be "MDR transporters," ABCC1 (MRP1) and ABCG2 (MXR or BCRP), were more weakly correlated with Positive correlations identify compounds potentiated by ABCB1 a smaller number of compounds, which did not include known substrates. The lack of the expected correlations may partially
The positive correlation between activity and ABCB1 expression for some of the compounds in Supplemental Table S5 suggests be explained by the statistical limitations of the correlative approach: the sample size (n ϭ 60), the experimental uncertainty, that those compounds can inhibit growth of the cancer cells more strongly if MDR1 is overexpressed. For some transporters, and the fact that multiple tests of significance are being done simultaneously may contribute to false negative predictions including MDR1, several high positive correlations between gene expression and drug sensitivity are higher than would be (hence, the "multiple testing" corrections we describe in the text and Experimental Procedures). There are also biological expected by random sampling from a distribution of no real underlying correlations (in the case of MDR1, for the top 10 limitations: first, as is the case for almost all transcript profiling studies, there remains uncertainty about the relationship bepositive correlations, the Benjamini-Hochberg procedure [Reiner et al., 2003 ] estimates on average 3 false positive predictions). tween mRNA and protein expression, and the relationship of both to function. As indicated in Supplemental Table S8 and Thus the toxicity of at least some of the compounds increases systematically with higher MDR1 expression in the NCI-60. To Supplemental Figure S2 at http://www.cancercell.org/cgi/content/ full/6/2/129/DC1, a comparison of the mRNA and protein exinvestigate that possibility, we used the MTT assay and the KB-3-1/KB-V1 cell pair to test the top-scoring compound that was pression profiles for ABCB1 and ABCG2, respectively, indicates that, at least for those two transporters, the real-time RT-PCR available from DTP ( Figure 5A ). Figure 5B shows that KB-V1 cells are 4-to 5-fold more sensitive than the parental KB-3-1. and protein expression data correlate quite well. Second, correlation does not imply causality. Third, there might be functionally
The finding that PSC 833 completely reversed sensitivity of KB-V1 cells to NSC 73306 strongly suggests that the increased relevant differences between the RNA messages that are not detected by RT-PCR measurements. That is, the 60 cells may sensitivity is due to the function of MDR1, not to other, nonspecific properties of the KB-V1 cells. contain splice variants or SNPs that influence the substrate specificities of the transporters (Imai et al., 2002; Honjo et al., To substantiate further that the observed potentiation of NSC 73306 was not due to nonspecific factors arising during 2002). Fourth, cofactors (e.g., conjugating enzymes) or transporters (e.g., ABCC1) may be expressed discordantly in the 60 the generation of KB-V1, we repeated the MTT assays using HeLa-transfectants in which human MDR1 is under tetracycline cells. Fifth, the ubiquitous and consistent expression of certain ABC transporters (e.g., ABCC1) makes it difficult to detect funccontrol. In these cells, addition of tetracycline suppresses transcription of MDR1 mRNA, and, over a period of a few days, tional relationships through correlations. Finally, the presence of MDR1 may mask the contribution of less potent transporters MDR1 disappears from the cells, providing a near-isogenic model for well-controlled experiments (Aleman et al., 2003) . of the same compounds. The somewhat surprising correlation of compounds with the expression of ABCD1, a peroxisomal Figure 5C shows that the MDR1-expressing cells (MDR1-On) are 2-to 4-fold more sensitive than are MDR1-Off cells, providhalf-transporter associated with adrenal leukodystrophy (Mosser et al., 1993) (Supplemental Table S6 ), is probably a conseing strong evidence that the increased sensitivity to NSC 73306 is mediated by MDR1 function. Interestingly, NSC 73306 does quence of the inverse correlation between the expression of ABCD1 and ABCB1 (r ϭ Ϫ0.48, see also Figure 1 and Supplenot block MDR1-mediated transport of other molecules (data not shown), suggesting that it might avoid the well-documented mental Table S1 ). Compounds showing inverse correlation with cell lines transfected with the appropriate ABC transporters. Although in some cases the levels of resistance were relatively low, ample evidence indicates that even low (2-to 4-fold) levels side effects observed in clinical trials of "classical" MDR1 inhibiof drug resistance can have a significant impact on the clinical tors (Kellen, 2003) . Possible explanations for the increased (colefficacy of anticancer treatment (Gottesman et al., 2002) . Animal lateral) sensitivity of otherwise resistant cells include ATP deplemodels have also demonstrated decreased responsiveness to tion (Kabanov et al., 2003) and altered activity of enzymes that chemotherapy in xenografts of a KB line selected for low levels influence the toxicity of the compound (Bergman et al., 2003) .
of in vitro resistance (Horton et al., 1988) . For many anticancer The results reported in this section suggest that the pharmacodrugs, toxic-to-therapeutic ratios are low and, therefore, even genomic approach presented here can be exploited to discover a small increase in cell-based resistance can hamper chemosuch MDR1-potentiated compounds, which may serve as leads therapy. for development of novel anticancer agents to treat resistant
The importance to cancer therapy of circumventing MDR is disease. Studies are underway to characterize other positively evident (Sikic, 1999) . Even precisely targeted anticancer drugs correlated compounds and to elucidate their mechanisms of are subject to mechanisms of resistance. The real-time RT-PCR action.
database presented here provides a means to identify (1) ABC transporters whose expression confers drug resistance, (2 focused on a subset consisting of 118 compounds whose mechanisms of action are putatively classifiable (Weinstein et al., 1992) and a larger set of with other molecules. In particular, these gene expression pro-1400 compounds that have been tested multiple times and whose screening files will aid studies of the physiological function of the many data met quality control criteria described elsewhere (Scherf et al., 2000) .
ABC transporters whose mechanisms remain to be characBoth sets are available at http://discover.nci.nih.gov. The two were combined terized.
to form a joint dataset that included 1429 compounds.
Experimental procedures Statistical analysis
The statistical analyses were performed using the SAS software package, Purification of RNA v8.2 (SAS Institute Inc, Cary, NC), and the R package (www.r-project.org). Using the RNeasy kit (Qiagen) according to the manufacturer's instructions, Two-dimensional agglomerative hierarchical cluster analysis, with average as described previously (Scherf et al., 2000) , we purified total RNA from linkage algorithm and distance metric 1Ϫr, where r is the Pearson correlation stocks of the cell lines used in the DTP screen. Aliquots of the RNA were coefficient, was performed using the CIMminer tool (http://discover.nci.nih. stored at Ϫ70ЊC. The quality (purity and integrity) of the RNA samples was gov) to group the 60 cell lines as well as 47 ABC transporters based on assessed using an Agilent 2100 Bioanalyzer with the RNA 6000 NanoLabChip the expression profiles. The resulting matrix of numbers was displayed in reagent set (Agilent Technologies) and by assessing the ribosomal RNA clustered image map form (Weinstein et al., 1997) as Figure 1 . bands on a native agarose gel. The RNA was quantitated using a spectrophoTo determine quantitatively how well the 47 genes cluster the cell lines tometer.
by their tissues of origin, we used a statistical method developed by S. Lababidi (unpublished data). In that method, the statistic is used to indicate Quantitative RT-PCR how well the observed clusters correspond to the nine tissue-of-origin classiExpression levels of 47 ABC transporters were measured by real-time quantifications. For that calculation, one cell line, UK: NCI-ADR-RES, was excluded tative RT-PCR using the LightCycler RNA Amplification SYBR Green kit because it did not clearly fit into any of the usual categories. and a LightCycler machine (Roche Biochemicals, Indianapolis, IN). Specific
To identify which genes are, on average, significantly over-or underexoligonucleotide probes were designed for each of the ABC transporters using pressed in cells from a given tissue of origin (in comparison with the rest of DNAStar Primer Select (DNASTAR Inc.), and they were then synthesized at the cell lines), we used Monte Carlo permutation t tests with 10,000 iterations Lofstrand Laboratories (Gaithersburg, MD). When possible, the amplicons to compare, for each tissue, the within-tissue mean and the mean over all were designed to encompass exon-intron boundaries to avoid amplification of the other tissue types (this approach avoids the assumption of normality of genomic DNA. The sequence of ABCA13 was not known when we assemand is suitable for small sample sizes). bled the PCR primers. Data reporting ABCA13 expression (Supplemental To narrow down the list of candidates based on correlation of the gene Table S1 at http://www.cancercell.org/cgi/content/full/6/2/129/DC1) were expression data for 48 ABC transporters and the extended list of 1429 drug taken from Prades et al., 2002 . Since the Syber Green assay detects accumuactivities measured in 60 cell lines (both centered around zero across the lation of double-stranded DNA, we selected those primers (from a battery cell lines as well as across the expression values or the drug activities, consisting of about 200 primers) that amplified a single product of the correct respectively), we calculated the 95% bootstrap confidence intervals of Pearsize. A list of the primers and corresponding gene reference/accession numson correlation coefficients for all of the possible relationships (a total of bers for the ABC proteins is shown in Supplemental Table S7 . RT-PCR was 48 ϫ 1429 ϭ 68,592 correlation coefficients). The bootstrap confidence carried out on 150 ng total RNA, in the presence of 250 nM specific primers. intervals were calculated using the empirical percentiles method with balFollowing reverse transcription (20 min at 55ЊC), the PCR reaction consisted anced resampling of 10,000 iterations (Chernick, 1999) . Balanced resampling of 45 cycles of denaturation (15 s at 95ЊC), annealing (30 s at 58ЊC), and forces each observation to appear exactly a number of times equal to the elongation (30 s at 72ЊC). No-template (water) reaction mixtures were pretotal number of iterations. By bootstrap resampling, we avoided parametric pared as negative controls.
assumptions about the distributions of the variables and incorporated possible non-normal distributional characteristics. For 10,000 bootstrap iterations Data processing with 95% confidence interval, the component of resampling error has a During the PCR amplification, fluorescence emission was measured and standard error of no more than 0.002. In recognition of the multiple testing recorded in real time by the LightCycler. Crossing point values were calcuproblem we preferred a stringent critical value of p ϭ 0.0001. To control the lated, using the LightCycler software package, by the Fit Points analysis overall false positive rate, we used both a step-down procedure (Westfall method, with baseline fluorescence set at 1. The SyberGreen assay meaand Young, 1993) and a step-up procedure (Reiner et al., 2003) to adjust sures accumulation of double-stranded products, and the appearance of for multiple testing of all 47 genes simultaneously. In the Benjamini-Hochberg primer dimers limits quantitation at high cycle numbers. The specificity of procedure, the p values are computed in the standard way by permutation, amplified products was verified by melting-curve analysis and agarose gel assuming that all distributions are exchangeable: the number of values in electrophoresis (not shown). The raw results were expressed as number of the permuted data with correlations over a threshold, divided by the number cycles to reach the crossing point. If the desired product was not detected, of compounds and by the number of permutations. We calculated the minithe corresponding value was adjusted to crossing points indicating no exmum FDR (q value) at which each compound would be declared using the pression. To assess the contribution of experimental artifacts, selected cell step-up procedure for positively correlated test statistics (again true because lines were assessed in replicate. The average pairwise correlation of replicate all correlations being compared are computed against the same ABC gene). expression profiles was 0.96. The reproducibility of the measurements was In this procedure, the first q value for the largest correlation is the Bonferronifurther confirmed by cluster analyses, which showed that replicates clustered corrected p value for that gene; then further q values are calculated as q j ϭ tightly together (data not shown).
max(p j *1429/j, q jϪ1 ). This procedure limits the expected proportion of false Since the expression levels of housekeeping genes (glyceraldehyde-3-positives in the list 1,…j to at most q j . phosphate dehydrogenase [GAPDH] , Porphobilinogen Deaminase [PBGD], tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, and zeta polypeptide [YWHAZ] ) were found to be highly variable among Drugs and chemicals The compounds designated here by NSC numbers were obtained from the 60 cell lines (not shown; however, see Vandesompele et al., 2002) , they were not used as controls, and data were normalized with respect to the the Drug Synthesis and Chemistry Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Instimean expression of the transporters (excluding ABCA13). Finally, the values were mean-centered and multiplied by Ϫ1 to indicate expression values tute. Colchicine and dimethyl sulphoxide (DMSO) were purchased from
